title: Encapsulated cell technology: from research to market.
abstract: Encapsulated cell technology has the potential to treat a wide range of diseases by the controlled and continuous delivery of biological products to the host. Many biotechnology companies have focused their interest in this technology taking into account the promising pre-clinical and clinical results and the potential clinical market. However, on the long way from clinic to market several issues will have to be addressed, including suitable scientific development, ethical obstacles, government regulations and market forces.
authors.affiliation: Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria-Gasteiz, Spain.
authors.forename: Gorka
authors.initials: G
authors.lastname: Orive
authors.forename: Rosa María
authors.initials: RM
authors.lastname: Hernández
authors.forename: Alicia R
authors.initials: AR
authors.lastname: Gascón
authors.forename: Manoli
authors.initials: M
authors.lastname: Igartua
authors.forename: José Luis
authors.initials: JL
authors.lastname: Pedraz
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000331:legislation & jurisprudence; D002214:Capsules; D017690:Cell Transplantation / Q000191:economics* / Q000331:legislation & jurisprudence / Q000379:methods* / Q000639:trends; D020099:Coated Materials, Biocompatible; D003132:Commerce; D003692:Delayed-Action Preparations / Q000191:economics; D003718:Denmark; D004337:Drug Carriers / Q000191:economics; D016503:Drug Delivery Systems / Q000191:economics* / Q000379:methods* / Q000639:trends; D004341:Drug Evaluation; D004345:Drug Industry / Q000191:economics; D005602:France; D006801:Humans; D014481:United States
chemical_list: D002214:Capsules; D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D004337:Drug Carriers